Zvakawanda Ozempic zvinoreva kudzora zviri nani pane Type 2 chirwere cheshuga

A BATA FreeRelease 8 | eTurboNews | eTN
Avatar of Linda Hohnholz
rakanyorwa Linda Hohnholz

Novo Nordisk nhasi yakazivisa kuti US Food and Drug Administration (FDA) yakabvumidza jekiseni re2 mg reOzempic® (semaglutide), kamwe chete pavhiki glucagon-like peptide-1 (GLP-1) analog inoratidzwa pamwe nekudya uye kurovedza muviri. kuvandudza shuga yeropa muvanhu vakuru vane chirwere cheshuga chechipiri uye kuderedza dambudziko rezviitiko zvakakura zvemwoyo zvakadai sekurwadziwa kwemoyo, sitiroko kana kufa kune vanhu vakuru vane chirwere cheshuga chechipiri uye chirwere chemoyo chinozivikanwa.2 Ozempic® haisi mishonga inoderedza uremu, asi inogona batsira vanhu kuderedza uremu. Ozempic® ichave iripo mumatatu matatu ekurapa (2 mg, 2 mg, uye 0.5 mg) kubatsira vanhu vane chirwere cheshuga cherudzi rwechipiri kusvika pashuga yavo yeropa (A1C) chinangwa, iko zvino kusanganisira avo vane A2C yakakwirira vasina kukwanisa kusangana navo. Chinangwa cheA2C.

Muchirongwa cheOzempic® SUSTAIN phase 3 chekiriniki chekuedza chirongwa, kusvika ku73% yevanhu vane chirwere cheshuga cherudzi rwechipiri vanobatwa neOzempic® 2 mg vakaderedza shuga yavo yeropa ndokusvika kuAmerican Diabetes Association chinangwa che <1%.7-3 Pasinei neizvi, ikoko vachiri vanhu vasiri pashuga yavo yeropa.5-1,4 Ozempic® 10 mg inobatsira avo vanoda kuwedzera glycemic control uye isarudzo inokosha kune varwere nevapepi mukurapa kunoenderera mberi kwechirwere cheshuga chechipiri.

"Type 2 chirwere cheshuga chirwere chakaoma chinogona kufambira mberi nekufamba kwenguva kunyange kana munhu achigadzirisa nemishonga, kudya uye kurovedza muviri," akadaro Dr Juan Pablo Frias, mutungamiriri wezvokurapa weVelocity Clinical Research, Los Angeles uye mukuru wekuongorora SUSTAIN FORTE, chikamu chechitatu chekiriniki yekuedza inotsigira Ozempic® 3 mg mvumo. "Nekuchengetedzeka kwayo uye kushanda kwayo, Ozempic® inobatsira kudzora shuga yeropa uye inopa hukuru hwekudzikisa njodzi yemoyo muvanhu vakuru vane Type 2 chirwere cheshuga uye chinozivikanwa chirwere chemoyo, pamwe chete inogona kubatsira varwere vazhinji kurasikirwa nehuremu. Tine 2 mg dose, isu tine imwe sarudzo kuitira kuti varwere varambe vari pamushonga mumwechete kunyangwe shuga yavo yeropa ichida kuchinja. "

Muchiyedzo cheSUSTAIN FORTE, vanhu vane avhareji yekutanga A1C ye8.9% vakarapwa neOzempic® 2 mg vakawana kuderedzwa kwakakosha uye kwepamusoro kweshuga yeropa ye2.1% pavhiki 40 zvichienzaniswa ne1.9% neOzempic® 1 mg (P<0.01 ) .1 Muchidzidzo chimwe chete, vanhu vane avhareji yekutanga uremu hwe219 lb vakarapwa neOzempic® 2 mg vakawana kuonda kwe14.1 lb zvichienzaniswa nekuderera kwe12.5 lb neOzempic® 1 mg; musiyano wakanga usiri wenhamba. Pamadhomu ese ari maviri eOzempic®, pakanga pasina zviratidzo zvitsva zvekuchengetedza zvakaonekwa.1 Zviitiko zvinonyanya kuipa ndezvemudumbu.1 Kusagadzikana kwemudumbu kunoitika kakawanda pakati pevarwere vaiwana Ozempic® 2 mg (34.0%) vs Ozempic® 1 mg (30.8% ).1

"Ozempic® iri padanho rekubatsira Novo Nordisk drive shanduko mukutarisira chirwere cheshuga, nevanhu vanopfuura miriyoni imwe vane chirwere cheshuga cherudzi rwechipiri muUnited States vanobatwa neOzempic®," akadaro Doug Langa, mutevedzeri wemutungamiri, North America mashandiro uye purezidhendi. yeNovo Nordisk Inc. "NeOzempic® ikozvino yave kuwanikwa mumhando dzakasiyana dzekusimba, tine tarisiro yekuti tinogona kubatsira vanhu vazhinji vanorarama nechirwere cheshuga cherudzi rwechipiri vanoda ruzivo rwekudzora shuga muropa zvakanakira Ozempic®."  

Novo Nordisk inotarisira kuvhura Ozempic® 2 mg muUnited States munguva pfupi. Ozempic® 2 mg yakabvumidzwa neSwitzerland Medic munaGunyana 2021 ichiteverwa neHealth Canada neEuropean Medicines Agency muna Ndira 2022.

Nezvomunyori

Avatar of Linda Hohnholz

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...